SCHEMBL30201491

SCHEMBL30201491

CCOC(=O)c1cnc2c(ccn2-c2ccc(C(N)=O)nc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.40
KIT P10721 1/20 0.40
SRC P12931 1/20 0.40
MAOB P27338 3/20 0.39
MMP2 P08253 1/20 0.38
MMP13 P45452 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HPGD P15428 2/20 0.37
HTT P42858 1/20 0.36
GRM2 Q14416 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
TYK2 P29597 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24942723 1.00 LCK (0.40) LCKKITSRCMAOBMMP2
SCHEMBL30201148 0.83 KMT2A (0.41) LCKKITSRCMAOBMAPT
SCHEMBL31038244 0.83 KMT2A (0.41) LCKKITSRCMAOBMAPT
SCHEMBL31038250 0.82 MAOB (0.40) LCKKITSRCMAOBPOLB
SCHEMBL31038247 0.82 MAOB (0.40) LCKKITSRCMAOBPOLB
SCHEMBL30201307 0.78 JMJD6 (0.36) LCKKITSRCMAOBMAPT
SCHEMBL24942726 0.78 JMJD6 (0.36) LCKKITSRCMAOBMAPT
SCHEMBL23680681 0.77 HPGD (0.64) ALDH1A1HPGDGRM2
SCHEMBL12670698 0.76 LCK (0.47) LCKKITSRCMAPTALDH1A1
SCHEMBL14175666 0.76 SRC (0.47) LCKKITSRCMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240294519-A1 PYRROLO[2,3-b]PYRIDINE PGDH INHIBITORS AND METHODS OF MAKING AND USING EPIRIUM BIO INC. 2024-09-05 US disclosed
EP-4376841-A1 PYRROLO[2,3-B]PYRIDINE PGDH INHIBITORS AND METHODS OF MAKING AND USING Epirium Bio Inc. (US) 2024-06-05 EP disclosed
WO-2023009642-A1 PYRROLO[2,3-B]PYRIDINE PGDH INHIBITORS AND METHODS OF MAKING AND USING EPIRIUM BIO INC. (US) 2023-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294519-A1 PYRROLO[2,3-b]PYRIDINE PGDH INHIBITORS AND METHODS OF MAKING AND USING HPGD, HPGDS, PTGIS LCK 4639/4885KIT 2550/4885SRC 4824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.